Abbott Laboratories (ABT)

EBITDA Growth

-52.26%

Quarterly · Period ending:

ABT logo

ABT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-52.26%
ABT Quarterly EBITDA YoY % (14.37% → -52.26%)
High-resolution chart · PNG

ABT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories EBITDA Growth — Quarterly
Period endingEBITDA Growth
7.6618%
-2.0893%
5.6071%
8.1636%
22.969%
6.4641%
-8.3767%
1.1665%
-11.7842%
5.6302%
12.4963%
6.5983%
9.889%
11.0582%
8.9387%
7.5887%
7.4179%
9.531%
8.7784%
8.6308%
11.9248%
12.5021%
15.379%
16.0239%
10.9819%
6.8876%
10.1962%
-1.7585%
7.8482%
21.7762%
16.7378%
27.8058%
2.7402%
78.8842%
7.356%
2.0784%
24.1495%
-34.0535%
12.3185%
11.3504%
9.2955%
6.2742%
12.461%
118.3826%
-68.801%
-66.6363%
-67.8503%
-6.8968%
8.0749%
7.2038%
9.0121%
-17.707%
11.158%
16.0831%
18.3901%
-15.141%
15.9209%
12.9531%
15.9792%
-11.8049%
14.3673%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.